Search

everythinglearnresearchcommunity

for

Search:↓

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Both birth control pills improved hormone levels and skin conditions in women with hyperandrogenism, but the one with drospirenone was more effective.

Men with early balding often have hormone levels similar to women with polycystic ovary syndrome.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Birth control pills are effective for treating women with too much male hormone.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Kidney stones and hair loss are significantly related in people under 60 years old.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Both oral contraceptives reduced acne effectively and had similar positive effects on skin oiliness and hair growth.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.